Pages that link to "Q40216459"
Jump to navigation
Jump to search
The following pages link to Parkinsonism, Lrrk2 G2019S, and tau neuropathology (Q40216459):
Displaying 50 items.
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update (Q22252904) (← links)
- LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6 (Q24296778) (← links)
- LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins (Q24300440) (← links)
- LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth (Q24304347) (← links)
- LRRK2 phosphorylates novel tau epitopes and promotes tauopathy (Q24338188) (← links)
- Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β (Q24338942) (← links)
- TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT (Q26851112) (← links)
- LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease (Q26861279) (← links)
- The regulation and deregulation of Wnt signaling by PARK genes in health and disease (Q26991986) (← links)
- High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain (Q27303568) (← links)
- Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score (Q29048624) (← links)
- Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2. (Q30454029) (← links)
- Exome sequencing in familial corticobasal degeneration (Q30583835) (← links)
- Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration (Q30653185) (← links)
- Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study (Q33300810) (← links)
- Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships (Q33689539) (← links)
- Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia (Q33727623) (← links)
- Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation (Q33808789) (← links)
- Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease (Q34113712) (← links)
- Role of LRRK2 kinase dysfunction in Parkinson disease (Q34192817) (← links)
- Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease (Q34481921) (← links)
- Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways (Q34550197) (← links)
- Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice (Q34723024) (← links)
- Genetic neuropathology of Parkinson's disease. (Q34825312) (← links)
- Models for LRRK2-Linked Parkinsonism (Q34986076) (← links)
- 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations (Q35004642) (← links)
- A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids (Q35142344) (← links)
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications (Q35148581) (← links)
- Saskatchewan movement disorders program (Q35559550) (← links)
- The many faces of tau (Q35870359) (← links)
- Clinical and pathological characteristics of LRRK2 G2019S patients with PD. (Q35911042) (← links)
- G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies (Q36143858) (← links)
- (G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD. (Q36223954) (← links)
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease (Q36325701) (← links)
- Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories (Q36359548) (← links)
- A Drosophila model for LRRK2-linked parkinsonism (Q36497497) (← links)
- Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? (Q36499640) (← links)
- α-Synuclein oligomers and clinical implications for Parkinson disease (Q36718306) (← links)
- Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations (Q36748778) (← links)
- LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease (Q36794416) (← links)
- Model fusion, the next phase in developing animal models for Parkinson's disease (Q36797994) (← links)
- Progressive supranuclear palsy: pathology and genetics (Q36817215) (← links)
- Deciphering the role of heterozygous mutations in genes associated with parkinsonism (Q36854642) (← links)
- LRRK2: an éminence grise of Wnt-mediated neurogenesis? (Q36888947) (← links)
- Genetics of Parkinson disease (Q37037053) (← links)
- Mutations in LRRK2 as a cause of Parkinson's disease (Q37039473) (← links)
- Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations (Q37081406) (← links)
- Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes (Q37243261) (← links)
- Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences. (Q37246534) (← links)
- Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions (Q37294382) (← links)